Thursday’s Top 4 Biotech Movers
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
All Work
Chris Lange
Why Investors Are Pulling Out Their Hair Over Aclaris Alopecia Study
Aclaris Therapeutics shares sharply dropped early on Thursday after the firm announced results from its midstage trial in alopecia areata.
What to Expect When Nike Reports on Thursday
Nike is scheduled to release its fiscal fourth-quarter financial results after the markets close on Thursday.
Should FedEx Get More Credit for Its Q4 Earnings?
FedEx shares moved little after the delivery giant released mixed fiscal fourth-quarter results.
Why General Mills Is Taking a Hit on Q4 Earnings
General Mills shares retreated after it reported mixed fiscal fourth-quarter financial results early Wednesday.
Big Biotechs Scare Off Short Sellers
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Short Sellers Seek Direction on Big Pharma
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Is Semiconductor Short Interest Signaling a Return to Market Highs?
The June 14 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
How Micron Pulled Ahead in Q3
Micron released its fiscal third quarter financial results after the markets closed on Tuesday. The company said that it had $1.05 in earnings per share (EPS) and $4.79 billion in revenue, compared with consensus…
What to Expect When Micron Reports After the Close
Micron Technology is scheduled to release its fiscal third-quarter financial results after the markets close on Tuesday.
Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?
Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and stock transaction valued at roughly $63 billion.
Is It Time to Back Off the Shopify Craze?
Shopify has proven to be one of the most outstanding stocks of 2019 thus far, but one analyst believes it’s time for buyers to take a breather.
Why Akorn Is in Trouble With the FDA Again
Akorn shares dipped on Tuesday after the firm announced that it received a warning letter from the FDA related to the inspection of its Somerset, New Jersey, manufacturing facility in July and August of…
Why China Is Turning Away From Big US Tech and Looking Within
China's PingCAP is competing in a sector traditionally dominated by companies such as Oracle and IBM, thus demonstrating the nation’s resurgent desire to "buy China."
Why All the Good News Is Priced Into Roku’s Stock
Roku has built an exceptional platform on the back of its players, and as it expands in the rapidly growing Smart TV category, it has positioned itself as best in class for OTT advertising…
Big Biotechs Scare Off Short Sellers
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Why the Cuba Ban Impact Looks Overdone in Cruise Line Stocks
Back in 2015, the Obama administration opened up travel to Cuba. This was great for cruise lines because they had another destination for passengers to book. However, recent developments have raised questions in this…
What to Expect When FedEx Reports Tuesday
Transportation giant FedEx is scheduled to release its fiscal fourth-quarter financial results after the markets close on Tuesday.
How Minerva Neursciences Is Outsmarting Insomia
Minerva Neurosciences saw its shares jump on Monday after the firm announced results from a trial related to an insomnia treatment.
Nike, Micron, Walgreens, FedEx, and More Major Earnings Coming This Week
We have included the consensus earnings estimates, as well as the stock price and trading history. Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies…